Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers.

Sarzani, Riccardo; Giulietti, Federico; Pentima, Chiara Di; Giordano, Piero; Spannella, Francesco

Sarzani, Riccardo; Giulietti, Federico; Pentima, Chiara Di; Giordano, Piero; Spannella, Francesco.

Afiliación

Sarzani R; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, IRCCS INRCA, Italy.
Giulietti F; Department of Clinical and Molecular Sciences, University 'Politecnica delle Marche', Italy.
Pentima CD; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, IRCCS INRCA, Italy.
Giordano P; Department of Clinical and Molecular Sciences, University 'Politecnica delle Marche', Italy.
Spannella F; Internal Medicine and Geriatrics, 'Hypertension Excellence Centre' of the European Society of Hypertension, IRCCS INRCA, Italy.

Eur J Prev Cardiol ; 28(16): e10-e13, 2022 01 11.

Article en En | MEDLINE | ID: mdl-33611416

Asunto(s)

Inhibidores de la Enzima Convertidora de Angiotensina; COVID-19; Humanos; Bloqueadores del Receptor Tipo 1 de Angiotensina II; Enzima Convertidora de Angiotensina 2; Sistema Renina-Angiotensina

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Enzima Convertidora de Angiotensina / COVID-19 Límite: Humans Idioma: En Revista: Eur J Prev Cardiol Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google